长非编码RNAVPS9D1-AS1通过调节VEGFA信号通路来促进结直肠癌中的血管生成
Zheying Zhang1, Yifei Han1, Yang Yang1
1Department of Pathology, Xinxiang Medical University Xinxiang 453003, Henan, China.
American journal of cancer research
|May 15, 2025
概括
长非编码RNAVPS9D1-AS1通过上调VEGFA和激活PI3K/AKT通路促进结直肠癌 (CRC) 血管生成. 这个过程是由转录因子CEBPB启动的,突出显示VPS9D1-AS1是CRC中的关键调节者.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 结肠直肠癌 (CRC) 是一个主要的全球健康问题.
- 血管新生在CRC进展和转移中发挥着关键作用.
- 长非编码RNAs (lncRNAs) 越来越多地被认为是癌症的关键调节者.
研究的目的:
- 阐明 lncRNA VPS9D1-AS1 影响结肠直肠癌血管生成的机制.
- 研究VPS9D1-AS1,VEGFA和CRC中的PI3K/AKT通路之间的调控关系.
- 在结直肠癌的背景下,确定VPS9D1-AS1的上游调节者.
主要方法:
- 定量实时PCR (qRT-PCR) 和西布洛特用于评估VPS9D1-AS1表达.
- 基于细胞的测试 (增殖,迁移,入侵,体外管形成) 使用人类静脉内皮细胞 (HUVEC).
- 染色体免疫沉 (ChIP) 和双化酶记者测试以确定转录因子的结合和活性.
主要成果:
- 发现VPS9D1-AS1在结直肠癌组织中表达高.
- 与VPS9D1-AS1的干扰抑制了HUVEC的扩散,迁移和入侵.
- VPS9D1-AS1通过上调VEGFA和激活PI3K/AKT通路来促进血管生成.
- 转录因子CEBPB直接与VPS9D1-AS1的促进子区域结合,从而增强其转录.
结论:
- VPS9D1-AS1通过促进血管生成,在结直肠癌中起到关键的瘤性 lncRNA 的作用.
- CEBPB是VPS9D1-AS1的上游激活剂,有助于其亲血管功能.
- VPS9D1-AS1代表了抑制结直肠癌血管生成的潜在治疗标.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
lncRNA - Long Non-coding RNAs
8.4K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.4K
Mechanism of Angiogenesis
5.1K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.1K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Non-Canonical Wnt Signaling Pathways
7.2K
Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...
7.2K


